UCLA Immunogenetics Center, Department of Pathology, David Geffen School of Medicine, University of California, 1000 Veteran Ave., Los Angeles, CA 90095, United States.
Hum Immunol. 2012 Dec;73(12):1239-44. doi: 10.1016/j.humimm.2012.06.013. Epub 2012 Jul 10.
The production of anti-donor antibodies to HLA class I and class II antigens following transplantation is associated with development of transplant vasculopathy and graft loss. Antibodies against HLA class I (HLA-I) molecules are thought to contribute to transplant vasculopathy by triggering signals that elicit the activation and proliferation of endothelial cells. The proximal molecular events that regulate HLA-I dependent signal transduction are not well understood. We demonstrated a mutual dependency between HLA-I and integrin β4 to stimulate signal transduction and cell proliferation. Similarly, we found that integrin β4-mediated cell migration was dependent upon its interactions with HLA-I molecules. Since integrin β4 has been implicated in angiogenesis and tumor formation, associations between integrin β4 and HLA-I may play an important role in cancer. Further characterization of interactions between HLA-I and integrin β4 may lead to the development of therapeutic strategies for the treatment and prevention of chronic allograft rejection and cancer.
移植后产生针对 HLA Ⅰ类和Ⅱ类抗原的抗供体抗体与移植血管病和移植物丢失的发生有关。人们认为针对 HLA Ⅰ类(HLA-I)分子的抗体通过触发引发内皮细胞激活和增殖的信号来促进移植血管病。调节 HLA-I 依赖性信号转导的近端分子事件尚不清楚。我们证明了 HLA-I 和整合素β4 之间的相互依赖性,以刺激信号转导和细胞增殖。同样,我们发现整合素β4 介导的细胞迁移依赖于其与 HLA-I 分子的相互作用。由于整合素β4 已被牵连到血管生成和肿瘤形成中,因此整合素β4 与 HLA-I 之间的关联可能在癌症中发挥重要作用。进一步表征 HLA-I 和整合素β4 之间的相互作用可能会导致开发出治疗慢性同种异体移植排斥和癌症的治疗策略。